|
⚲
|
| Keyboard |
| Third Rock Ventures GP II LP | |
|---|---|
| Firm | Third Rock Ventures LLC |
| Address | 29 Newbury Street 3rd Floor Boston, MA 02116 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Third Rock Ventures LLC | |||||
| Third Rock Ventures II LP | 021-140348 | Executive Officer | of 400.0 M |
7.9 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Jounce Therapeutics Inc JNCE
Common Stock
|
2021-09-15 | Other | 1,750,000 | ||
|
Jounce Therapeutics Inc JNCE
Common Stock
|
2021-06-10 | Other | 1,500,000 | ||
|
Revolution Medicines Inc RVMD
Common Stock
|
2021-06-04 | Sell | 164,996 | $30.23 | 4,987,829 |
|
Revolution Medicines Inc RVMD
Common Stock
|
2021-06-03 | Sell | 378,117 | $30.20 | 11,419,133 |
|
Revolution Medicines Inc RVMD
Common Stock
|
2021-05-26 | Sell | 1,231,204 | $30.53 | 37,588,658 |
|
Jounce Therapeutics Inc JNCE
Common Stock
|
2021-05-25 | Sell | 552,520 | $8.00 | 4,420,160 |
|
Revolution Medicines Inc RVMD
Common Stock
|
2021-05-25 | Sell | 135,000 | $30.93 | 4,175,550 |
|
Jounce Therapeutics Inc JNCE
Common Stock
|
2021-03-11 | Other | 1,250,000 | ||
|
Jounce Therapeutics Inc JNCE
Common Stock
|
2021-03-01 | Sell | 1,450,000 | $11.75 | 17,037,500 |
|
Jounce Therapeutics Inc JNCE
Common Stock
|
2020-11-19 | Sell | 15,000 | $7.01 | 105,150 |
|
Jounce Therapeutics Inc JNCE
Common Stock
|
2020-11-17 | Sell | 15,000 | $7.25 | 108,750 |
|
Jounce Therapeutics Inc JNCE
Common Stock
|
2020-11-11 | Other | 1,000,000 | ||
|
Revolution Medicines Inc RVMD
Common Stock
|
2020-02-18 | Conversion | 1,909,317 | ||
|
Revolution Medicines Inc RVMD
Common Stock
|
2020-02-18 | Conversion | 8,613,025 | ||
|
Revolution Medicines Inc RVMD
Series B Preferred Stock · derivative
|
2020-02-18 | Conversion | 1,909,317 | $0.00 | |
|
Revolution Medicines Inc RVMD
Series C Preferred Stock · derivative
|
2020-02-18 | Conversion | 49,879 | $0.00 | |
|
Revolution Medicines Inc RVMD
Series A Preferred Stock · derivative
|
2020-02-18 | Conversion | 8,220,641 | $0.00 | |
|
Revolution Medicines Inc RVMD
Series B Preferred Stock · derivative
|
2020-02-18 | Conversion | 342,505 | $0.00 | |
|
MyoKardia Inc MYOK
Common Stock
|
2018-03-07 | Other | 2,000,000 | ||
|
MyoKardia Inc MYOK
Common Stock
|
2017-12-06 | Other | 2,000,000 | ||
| showing 20 of 100 most recent transactions | |||||